NORAD-Regulated Signaling Pathways in Breast Cancer Progression
Cancers · 01.02.2024 · 16 (3) · 636
DOI: 10.3390/cancers16030636 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 01.02.2024. Verfasst von Ana Maria Capela und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Liga Portuguesa Contra o Cancro, FEDER.
Abstract (Originalsprache)
Long non-coding RNA activated by DNA damage (NORAD) has recently been associated with pathologic mechanisms underlying cancer progression. Due to NORAD’s extended range of interacting partners, there has been contradictory data on its oncogenic or tumor suppressor roles in BC. This review will summarize the function of NORAD in different BC subtypes and how NORAD impacts crucial signaling pathways in this pathology. Through the preferential binding to pumilio (PUM) proteins PUM1 and PUM2, NORAD has been shown to be involved in the control of cell cycle, angiogenesis, mitosis, DNA replication and transcription and protein translation. More recently, NORAD has been associated with PUM-independent roles, accomplished by interacting with other ncRNAs, mRNAs and proteins. The intricate network of NORAD-mediated signaling pathways may provide insights into the potential design of novel unexplored strategies to overcome chemotherapy resistance in BC treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences, Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal.
ORCID-Profile: Ana Maria Capela, Carlota Tavares-Marcos, Sandrina Nóbrega-Pereira, Bruno Bernardes de Jesus
Förderung
- Fundação para a Ciência e Tecnologia
- Liga Portuguesa Contra o Cancro
- FEDER
- FCT CEECIND Program
- FCT predoctoral fellowship
Zitieren
APA
Capela, A. M., Tavares-Marcos, C., Estima-Arede, H. F., Nóbrega-Pereira, S., & Bernardes de Jesus, B. (2024). NORAD-Regulated Signaling Pathways in Breast Cancer Progression. Cancers, 16(3), 636. https://doi.org/10.3390/cancers16030636
Vancouver
Capela AM, Tavares-Marcos C, Estima-Arede HF, Nóbrega-Pereira S, Bernardes de Jesus B. NORAD-Regulated Signaling Pathways in Breast Cancer Progression. Cancers. 2024;16(3):636. doi:10.3390/cancers16030636
BibTeX
@article{Capela2024,
author = {Capela, Ana Maria and Tavares-Marcos, Carlota and Estima-Arede, Hugo F and Nóbrega-Pereira, Sandrina and Bernardes de Jesus, Bruno},
title = {NORAD-Regulated Signaling Pathways in Breast Cancer Progression},
journal = {Cancers},
year = {2024},
volume = {16},
number = {3},
pages = {636},
doi = {10.3390/cancers16030636}
}
EUVIMED